|File Size||321.58 KB|
|Create Date||October 4, 2017|
|Last Updated||October 12, 2017|
<strong>Bio-Gene Technology Limited Prospectus Download</strong>
Bio-Gene Technology Limited (ACN 071 735 950) (“Bio-Gene” or “the Company”) lodged a prospectus (Prospectus) with the Australian Securities and Investments Commission (“ASIC”) on 5 October 2017 for an offer of shares to raise $7 million (with the ability to accept oversubscriptions up to a further $1 million) before costs of the offer (“the Prospectus”).
Applications can be made using the Share Registry’s online application facility available at <a href="https://investor.automic.com.au/bio-gene.html" target="_blank">https://investor.automic.com.au/bio-gene.html</a>
An electronic copy of the Prospectus can be obtained in PDF format by clicking below after confirming agreement to the following.
This is important information that should be read in its entirety. If you do not understand it you should consult your professional adviser without delay. The expiry date of the Prospectus is the date that is 13 months from the date of lodgement of the Prospectus. The paper form of the electronic Prospectus (including its attached application form) accessible through this website has been lodged with ASIC.
Applications for securities referred to in the Prospectus must be made in accordance with the terms and conditions of the Prospectus. Applications for securities must be made on an application form that accompanied a complete hard copy of the Prospectus or the complete unaltered electronic version of the Prospectus.
The Prospectus does not constitute an offer in any place in which, or to any person to whom, it will not be lawful to make such an offer. No action has been taken to lodge, register or file the Prospectus in any jurisdiction outside Australia. The distribution of this Prospectus outside Australia may be restricted by law and persons who come into possession of this Prospectus outside Australia should seek advice on and observe any such restrictions. The investment described in this Prospectus has not been recommended by any regulatory authority of any jurisdiction including ASIC.
The information on this website is provided for information purposes only and is subject to change without notice. Nothing contained on this website or in the Prospectus constitutes investment, legal, account, business, tax or other advice, nor is it to be relied on in making an investment in Bio-Gene. The information on this website and in the Prospectus does not take into account your investment objectives, financial situation or particular needs.
Persons who receive a copy of this Prospectus in electronic format are entitled to obtain a hard copy of the Prospectus free of charge during the offer period by telephoning Roger McPherson, the Company Secretary, on (03) 9628 4178.
By accessing the Prospectus you are taken to have confirmed that you have read and understood the notice and agree to these terms.